810nm激光睫状体光凝治疗难治性青光眼的疗效  

Effect observation of 810nm laser cyclophotocoagulation for refractory glaucoma

作　　者：底煜[1] 归东海[1] 聂庆珠[1] 盖春柳[1] 杨宏伟[1] 陈晓隆[1] 

机构地区：[1]中国医科大学附属盛京医院眼科,中国辽宁省沈阳市110004

出　　处：《国际眼科杂志》2013年第3期515-516,共2页International Eye Science

摘　　要：目的:探讨810nm激光经巩膜睫状体光凝治疗难治性青光眼的临床疗效。方法:对25例30眼难治性青光眼患者行810nm激光经巩膜睫状体光凝术,术后随访3mo,分析术后眼压、疼痛感、视力、并发症等情况。结果:术后随访期间全部患者眼痛症状均缓解。术前平均眼压为50.42±2.50mmHg,末次随访时平均眼压15.95±4.19mmHg,术后眼压与术前相比,差异有显著统计学意义(P<0.01)。光凝术后2眼(6.7%)视力提高,24眼(80.0%)视力无变化,4眼(13.3%)视力下降。术后前房渗出12眼(40.0%),前房积血3眼(10.0%),玻璃体积血1眼(3.3%),药物治疗后消失。结论:810nm激光经巩膜睫状体光凝术是治疗难治性青光眼的有效方法,能显著降低眼压,减少患者痛苦,并发症少。· AIM： To investigate the therapeutic effects of transscleral cyclophotocoagulation procedures （TCP） with 810nm laser for refractory glaucoma. · METHODS： Totally 25 patients （30 eyes） with refractory glaucoma were treated with TCP. The follow-up time was 3 months, the patients＇ symptom, intraocular pressure （ IOP）, visual acuity and complications were analyzed. · RESULTS： During the follow-up period, all patients＇ ocular pain was reduced. The mean lOP before TCP and at the last follow-up time were （50.42±2.50） mmHg（1kPa = 7.5mmHg） and （15. 95±4.19）mmHg, respectively, the lOP decreased after TCP, there was significant difference （P〈 0. 001 ）. After TCP, the visual acuity improved in 2 eyes （6. 7%）, had no change in 24 eyes （80. 0%）, decreased in 4 eyes （·13.3%）. After TCP, the exudation of anterior chamber appeared in 12 eyes （40.0%）, hyphema of anterior chamber appeared in 3 eyes （10.0%）, vitreous hemorrhage in 1 eye （3.3%）, which were all cured after drug treatment. · CONCLUSION： TCP with 810nm laser in treatment of refractory glaucoma has curative effect, can degrade the lOP, lessen ocular pain and with few complications.

关 键 词：810nm激光 睫状体光凝 难治性青光眼 

分 类 号：R779.63[医药卫生—眼科]